Capcom has provided a sales update for all of its best-selling games, as part of its second-quarter results for fiscal year 2026. And it’s business as usual for the publisher: its legacy titles continue to sell strongly, and Capcom’s new releases are performing well too.
Looking at its three biggest hitters for 2026, Resident Evil Requiem has now sold 8.51 million copies, Pragmata is now at 2.73 million units, and Onimusha: Way of the Sword has managed 1.78 million sales after almost two months on the market.
This means in the second quarter of this current fiscal year, Requiem sold another 450,000 units, while Pragmata added 229,000 copies to its lifetime sales total.
Elsewhere on the graph, the sales of Capcom’s older titles continue to impress. Resident Evil 4 was the publisher’s second-best-selling game of the quarter, with 1.1 million copies sold. Resident Evil 2 managed 640,000, Devil May Cry 5 did 540,000 units, and Resident Evil 7: Biohazard shifted another 460,000 copies.
The only failure is Monster Hunter Wilds; it’s been outsold by 2018’s Monster Hunter World in Q2 — that’s why it doesn’t even appear on the table above.
With today’s sales totals added on, the Resident Evil series has now cumulatively sold 218 million units, the Monster Hunter franchise has sold 132 million copies, and Street Fighter sits at 60 million sales.
Capcom then looks ahead to its 2027 releases, highlighting Mega Man: Dual Override, the Ascendance expansion to Monster Hunter Wilds, and Resident Evil Veronica.
Did you buy many of these Capcom games in the past few months? Let us know in the comments below.
